Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ghio

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Transfusion|August 9, 2001
In vitro immunosuppressive activity of soluble HLA class I and Fas ligand molecules: do they play a role in autologous blood transfusion?M Ghio, P Contini, C Mazzei, et al.
International Immunology|February 2, 2000
Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8(+) Fas (CD95)(+) T lymphocytesF Puppo, P Contini, M Ghio, et al.
Reumatismo|April 24, 2004
[Nailfold videocapillaroscopy in systemic sclerosis: diagnostic and follow-up parameters and correlation with both specific serum autoantibodies and subsets of skin involvement]A Sulli, A Burroni, M Tuccio, et al.
Journal of Clinical Immunology|July 1, 1995
Behavior of soluble HLA class I antigens in patients with chronic hepatitis C during interferon therapy: an early predictor marker of response?F Puppo, A Picciotto, S Brenci, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 2001
Impairment of CD8+ T suppressor cell function in patients with active systemic lupus erythematosusG Filaci, S Bacilieri, M Fravega, et al.
Microvascular Research|April 12, 2019
Correlations between nailfold microvascular damage and skin involvement in systemic sclerosis patientsB Ruaro, C Pizzorni, S Paolino, et al.
Human Immunology|July 1, 1994
HLA class-I-soluble antigen serum levels in liver transplantation. A predictor marker of acute rejectionF Puppo, R Pellicci, S Brenci, et al.
Journal of Clinical Immunology|February 24, 2001
Soluble beta2-mu-associated and beta2-mu-free HLA class I heavy chain serum levels in interferon-alpha nonresponder chronic hepatitis C patients. Markers of immune activation, and response to antiviral retreatmentF Puppo, F Torre, P Contini, et al.
Tissue Antigens|April 15, 1999
Beta2-micro-free HLA class I heavy chain levels in sera of healthy individuals. Lack of association with beta2-micro-associated HLA class I heavy chain levels and HLA phenotypeF Puppo, D Bignardi, P Contini, et al.
Rheumatology (Oxford, England)|January 22, 2004
Blunted coronary flow reserve in systemic sclerosisA Sulli, M Ghio, G P Bezante, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Transfusion|August 9, 2001
In vitro immunosuppressive activity of soluble HLA class I and Fas ligand molecules: do they play a role in autologous blood transfusion?M Ghio, P Contini, C Mazzei, et al.
International Immunology|February 2, 2000
Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8(+) Fas (CD95)(+) T lymphocytesF Puppo, P Contini, M Ghio, et al.
Reumatismo|April 24, 2004
[Nailfold videocapillaroscopy in systemic sclerosis: diagnostic and follow-up parameters and correlation with both specific serum autoantibodies and subsets of skin involvement]A Sulli, A Burroni, M Tuccio, et al.
Journal of Clinical Immunology|July 1, 1995
Behavior of soluble HLA class I antigens in patients with chronic hepatitis C during interferon therapy: an early predictor marker of response?F Puppo, A Picciotto, S Brenci, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 2001
Impairment of CD8+ T suppressor cell function in patients with active systemic lupus erythematosusG Filaci, S Bacilieri, M Fravega, et al.
Microvascular Research|April 12, 2019
Correlations between nailfold microvascular damage and skin involvement in systemic sclerosis patientsB Ruaro, C Pizzorni, S Paolino, et al.
Human Immunology|July 1, 1994
HLA class-I-soluble antigen serum levels in liver transplantation. A predictor marker of acute rejectionF Puppo, R Pellicci, S Brenci, et al.
Journal of Clinical Immunology|February 24, 2001
Soluble beta2-mu-associated and beta2-mu-free HLA class I heavy chain serum levels in interferon-alpha nonresponder chronic hepatitis C patients. Markers of immune activation, and response to antiviral retreatmentF Puppo, F Torre, P Contini, et al.
Tissue Antigens|April 15, 1999
Beta2-micro-free HLA class I heavy chain levels in sera of healthy individuals. Lack of association with beta2-micro-associated HLA class I heavy chain levels and HLA phenotypeF Puppo, D Bignardi, P Contini, et al.
Rheumatology (Oxford, England)|January 22, 2004
Blunted coronary flow reserve in systemic sclerosisA Sulli, M Ghio, G P Bezante, et al.
Pageof 3